Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...
So, which respiratory virus invaded your cells? Several types of viruses could be the culprit: respiratory syncytial virus ...
Respiratory syncytial virus, or RSV, is a common virus that infects the nose, throat and lungs, according to the U.S. Centers ...
RSVpreF vaccination is effective against RSV-related lower respiratory tract disease among adults aged 60 years or older.
The respiratory syncytial virus (RSV) vaccine may not protect older adults who are immunocompromised as much as their healthier peers, according to new research.